Transsklerale Zyklophotokoagulation als primäre antiglaukomatöse Operation

Winkler, Niklas; Funk, Jens

doi:10.1055/s-0032-1328359

Cited by 8 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This mean reduction of 1.6 glaucoma medications is greater than the reduction of 1.3 medications found with the standard TSCPC technique of Winkler and associates, and 0.9 medications reported by Khodeiry and associates utilizing similar slow-coagulation techniques. 16 , 30 The mean IOP and number of medications continued to be lower than baseline values throughout 11.7 ± 8.5 months of follow-up, suggesting the persistence of IOP-lowering and decrease in medications dependence effects of SC-TSCPC even up to the first year. Studies with longer follow-up periods would be required to confirm the long-term efficiency of SC-TSCPC on these outcomes.…”

Section: Discussionmentioning

confidence: 92%

Outcomes of slow coagulation transscleral cyclophotocoagulation in a predominantly African American glaucoma population

Parekh,

Wang,

Qiu

2024

American Journal of Ophthalmology Case Reports

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 92%

Outcomes of slow coagulation transscleral cyclophotocoagulation in a predominantly African American glaucoma population

Parekh,

Wang,

Qiu

2024

American Journal of Ophthalmology Case Reports

View full text Add to dashboard Cite

“…Eine potenzielle Auswirkung auf nachfolgende mikrochirurgische Glaukomprozeduren im Trabekelmaschenwerk und Suprachoroidalraum ist denkbar, Daten hierzu gibt es bisher allerdings nicht. Nicht selten sind mehrere Sitzungen an einem Auge möglich und nötig, um die angestrebte Drucksenkung zu erreichen [10]. Die Wirksamkeit einer 2.…”

Section: Einführungunclassified

Zyklodestruktive Verfahren zur Senkung des Augeninnendrucks – eine Übersicht

Jurjevic

Funk

Töteberg‐Harms

2017

Klin Monatsbl Augenheilkd

View full text Add to dashboard Cite

The only therapy for glaucoma, for which there is sufficient evidence, is the lowering of intraocular pressure. Intraocular pressure reduction can be achieved by an improvement in outflow or a reduction of aqueous humor production. Surgically, a reduction of aqueous humor production can be achieved by cyclodestructive procedures. This article provides a brief summary of the different cyclodestructive procedures. The efficacy of cyclophotocoagulation is well documented. The risk profile has been reduced by changes in the laser protocols. Serious complications described in early studies (e.g., visual loss) rarely occur nowadays. The indication spectrum of cyclophotocoagulation has expanded from end-stage glaucoma to glaucoma with good visual acuity. Even the use of cyclodestructive procedures in pediatric glaucoma has gained acceptance. A promising next generation of micropulsed diode lasers could further reduce the risk profile with the same effectiveness. The non-inferiority of micropulse cyclophotocoagulation versus the established procedures has been proven in early studies. However, studies with long-term follow-up and on side-effects are still lacking. Furthermore, a standardized laser protocol must be established.

show abstract